Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OMNICELL, INC. Director's Dealing 2025

Mar 18, 2025

31980_dirs_2025-03-18_41bc2b3a-bc60-4286-bdae-dcacab8c3327.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, INC. (OMCL)
CIK: 0000926326
Period of Report: 2025-03-14

Reporting Person: LIPPS RANDALL A (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-14 Common Stock P 10561 $33.1289 Acquired 333610 Direct
2025-03-15 Common Stock A 79494 Acquired 413104 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 355861 Indirect
Common Stock 8051 Indirect

Footnotes

F1: Shares held in trust with Mr. Lipps' wife.

F2: Shares held in trust for the benefit of Mr. Lipps' children.

F3: The price reported in Column 4 is a weighted average price of $33.1289 The purchase price range between $32.745 to $33.44 The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F4: Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on March 15, 2026. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 5/15; (ii) 8/15; (iii) 11/15; and (iv) 2/15.